Agrolimab News Today : Breaking News, Live Updates & Top Stories | Vimarsana

The phase 3 ENHANCE-3 study of magrolimab plus venetoclax/azacitidine vs venetoclax/azacitidine in select patients with AML has been terminated.

Merdad parseyGilead sciences incWorld health organizationGilead sciencesAcute myeloid leukemiaPhase 3 enhance study nct04313881Acute myeloid leukemia aml